Related Experiment Video
Updated: Sep 30, 2025

Visual Detection of Multiple Nucleic Acids in a Capillary Array
Published on: November 15, 2017
Visual Detection of ACE I/D Polymorphism Using T-ARMS-PCR Combined with a Lateral Flow Assay and Its Clinical
Yu Cai1,2, Sinong Zhang1,2, Jiaxing Zhang1,2
1College of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, China.
A new biosensor combines tetra-primer amplification refractory mutation system polymerase chain reaction (T-ARMS-PCR) and lateral flow assay (LFA) for rapid, visual genotyping of insertion/deletion (indel) variations. This T-ARMS-PCR-LFA method offers a simple, accurate, and cost-effective solution for disease marker detection.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Insertion/deletion (indel) variations are key disease markers.
- Current indel genotyping methods are complex, time-consuming, and costly.
- There is a need for rapid, point-of-care diagnostic tools.
Purpose of the Study:
- To develop a fast and accurate biosensor for visual indel genotyping.
- To enable point-of-care testing for genetic variations.
- To simplify the process of genotyping specific large indel variants.
Main Methods:
- Developed a biosensor combining tetra-primer amplification refractory mutation system polymerase chain reaction (T-ARMS-PCR) and GoldMag lateral flow assay (LFA).
- Utilized four primers in a single PCR reaction for distinguishing ACE I/D polymorphism.
- Visual genotyping results obtained within 5 minutes via LFA strip color changes.
Main Results:
- The T-ARMS-PCR-LFA system accurately genotyped ACE I/D polymorphism in 50 human DNA samples with 100% accuracy.
- Successful genotyping was achieved with a low DNA input (25 ng).
- The method eliminated complex operation steps and data analysis compared to conventional methods like agarose gel electrophoresis.
Conclusions:
- The T-ARMS-PCR-LFA biosensor provides a rapid, accurate, and visually interpretable method for indel genotyping.
- This technology is highly applicable for clinical practices, enabling faster decision-making in disease diagnosis.
- The biosensor facilitates personalized medicine by simplifying genetic variant analysis.
More Related Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
06:53Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019